Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2017

01-05-2017 | Erratum

Erratum to: Gastrointestinal stromal tumors (GISTs): SEAP–SEOM consensus on pathologic and molecular diagnosis

Authors: J. Martin-Broto, V. Martinez-Marín, C. Serrano, N. Hindi, J. A. López-Guerrero, M. Biscuola, R. Ramos-Asensio, A. Vallejo-Benítez, D. Marcilla-Plaza, R. González-Cámpora

Published in: Clinical and Translational Oncology | Issue 5/2017

Login to get access

Excerpt

Due to an unfortunate error, Michele Bisculoa was omitted from the list of authors in the original article. The correct authorship of this article is as follows: …
Metadata
Title
Erratum to: Gastrointestinal stromal tumors (GISTs): SEAP–SEOM consensus on pathologic and molecular diagnosis
Authors
J. Martin-Broto
V. Martinez-Marín
C. Serrano
N. Hindi
J. A. López-Guerrero
M. Biscuola
R. Ramos-Asensio
A. Vallejo-Benítez
D. Marcilla-Plaza
R. González-Cámpora
Publication date
01-05-2017
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 5/2017
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-017-1619-0

Other articles of this Issue 5/2017

Clinical and Translational Oncology 5/2017 Go to the issue

Research Article

High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer

Review Article

A consensus statement on the gender perspective in lung cancer

Research Article

CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker

Research Article

Knockdown of OCT4 may sensitize NSCLC cells to cisplatin

Special Article

Gastrointestinal stromal tumors (GISTs): SEAP–SEOM consensus on pathologic and molecular diagnosis

Research Article

Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits